Literature DB >> 9990301

Identification and cloning of a novel phosphatase expressed at high levels in differentiating growth plate chondrocytes.

B Houston1, E Seawright, D Jefferies, E Hoogland, D Lester, C Whitehead, C Farquharson.   

Abstract

Growth plate chondrocytes progress through a proliferative phase before acquiring a terminally-differentiated phenotype. In this study we used Percoll density gradients to separate chick growth plate chondrocytes into populations of different maturational phenotype. By applying agarose gel differential display to these populations we cloned a cDNA encoding a novel 268 amino acid protein (3X11A). 3X11A contains two peptide motifs that are conserved in a recently identified superfamily of phosphotransferases. It is likely that 3X11A is a phosphatase, but its substrate specificity remains uncertain. 3X11A expression is upregulated 5-fold during chondrocyte terminal differentiation and its expression is approximately 100-fold higher in hypertrophic chondrocytes than in non-chondrogenic tissues. This suggests that 3X11A participates in a biochemical pathway that is particularly active in differentiating chondrocytes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9990301     DOI: 10.1016/s0167-4889(98)00153-0

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  21 in total

1.  LEPS2, a phosphorus starvation-induced novel acid phosphatase from tomato.

Authors:  J C Baldwin; A S Karthikeyan; K G Raghothama
Journal:  Plant Physiol       Date:  2001-02       Impact factor: 8.340

2.  Characterization of subpopulated articular chondrocytes separated by Percoll density gradient.

Authors:  Byoung-Hyun Min; Hyeon Joo Kim; Hanjo Lim; So Ra Park
Journal:  In Vitro Cell Dev Biol Anim       Date:  2002-01       Impact factor: 2.416

3.  A distinctive patchy osteomalacia characterises Phospho1-deficient mice.

Authors:  Alan Boyde; Katherine A Staines; Behzad Javaheri; Jose Luis Millan; Andrew A Pitsillides; Colin Farquharson
Journal:  J Anat       Date:  2017-08       Impact factor: 2.610

4.  Inhibition of PHOSPHO1 activity results in impaired skeletal mineralization during limb development of the chick.

Authors:  Vicky E Macrae; Megan G Davey; Lynn McTeir; Sonoko Narisawa; Manisha C Yadav; Jose Luis Millan; Colin Farquharson
Journal:  Bone       Date:  2010-01-04       Impact factor: 4.398

5.  Human PHOSPHO1 exhibits high specific phosphoethanolamine and phosphocholine phosphatase activities.

Authors:  Scott J Roberts; Alan J Stewart; Peter J Sadler; Colin Farquharson
Journal:  Biochem J       Date:  2004-08-15       Impact factor: 3.857

Review 6.  Ultrastructure and biological function of matrix vesicles in bone mineralization.

Authors:  Tomoka Hasegawa
Journal:  Histochem Cell Biol       Date:  2018-02-06       Impact factor: 4.304

7.  PHOSPHO1 is essential for mechanically competent mineralization and the avoidance of spontaneous fractures.

Authors:  Carmen Huesa; Manisha C Yadav; Mikko A J Finnilä; Simon R Goodyear; Simon P Robins; K Elizabeth Tanner; Richard M Aspden; José Luis Millán; Colin Farquharson
Journal:  Bone       Date:  2011-01-25       Impact factor: 4.398

Review 8.  The role of phosphatases in the initiation of skeletal mineralization.

Authors:  José Luis Millán
Journal:  Calcif Tissue Int       Date:  2012-11-27       Impact factor: 4.333

9.  Design, synthesis and evaluation of benzoisothiazolones as selective inhibitors of PHOSPHO1.

Authors:  Yalda Bravo; Peter Teriete; Raveendra-Panickar Dhanya; Russell Dahl; Pooi San Lee; Tina Kiffer-Moreira; Santhi Reddy Ganji; Eduard Sergienko; Layton H Smith; Colin Farquharson; José Luis Millán; Nicholas D P Cosford
Journal:  Bioorg Med Chem Lett       Date:  2014-07-15       Impact factor: 2.823

10.  Pharmacological inhibition of PHOSPHO1 suppresses vascular smooth muscle cell calcification.

Authors:  Tina Kiffer-Moreira; Manisha C Yadav; Dongxing Zhu; Sonoko Narisawa; Campbell Sheen; Boguslaw Stec; Nicholas D Cosford; Russell Dahl; Colin Farquharson; Marc F Hoylaerts; Vicky E Macrae; José Luis Millán
Journal:  J Bone Miner Res       Date:  2013-01       Impact factor: 6.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.